作者
Mari Minasyan,Aleksandra Gamrat-Żmuda,Maria Borysowicz,Alicja Hubalewska–Dydejczyk,Aleksandra Gilis‐Januszewska
摘要
Abstract Introduction Mild autonomous cortisol secretion (MACS) is a condition of mild cortisol excess due to autonomous secretion by adrenal tumor(s). Patients lack typical Cushing syndrome symptoms but face increased risks of cardiovascular, metabolic, and skeletal complications. Materials and Methods We reviewed clinical characteristics of MACS patients hospitalized at a reference endocrinology center in southeastern Poland from 2018-2024. Inclusion criteria: serum cortisol ≥1.8 µg/dL in 1 mg dexamethasone suppression test (post-DST), ACTH ≤ 20 pg/mL, benign adrenal lesion(s) on imaging. Exclusion criteria: active malignancy, steroid therapy, active infection, alcohol abuse. Results A total of 203 patients fulfilled inclusion criteria (74% women; mean age 67 ± 10 years). Mean ACTH concentration was 12.7 ± 4.4 pg/mL, and median post-DST cortisol was 2.83 µg/dL (IQR 1.8-13.9). All patients were referred for evaluation of adrenal incidentalomas. Imaging revealed bilateral adenomas in 37.5%, unilateral left adenomas in 36.5%, unilateral right adenomas in 22%, adrenal hyperplasia in 3.5%, and adrenal trunk thickening in 0.5%. ARMC5 mutations were identified in 7% of patients with bilateral adenomas. Comorbidities were highly prevalent: obesity in 40.5%, overweight in 28%, and disturbances of glucose metabolism in 48%, including poorly controlled diabetes in 23%. Hypertension was present in 84%, with poor control in 23%, dyslipidemia in 71%, and coronary heart disease in 20%. Pathological fractures occurred in 11% of patients, predominantly vertebral (73%). Osteoporosis or osteopenia of the femoral neck was detected in 12.8%, and of the lumbar spine in 13%. Hepatic complications icluded isolated steatosis in 14%, isolated elevation of liver enzymes in 15%, and both in 7.5%. Thromboembolic events were documented in 5.4%, including deep vein thrombosis (64%), pulmonary embolism (27%) and both in 9%. Psychiatric manifestations included depression (12.8%), anxiety (4.5%), and insomnia (4.5%). Nineteen patients underwent adrenal surgery. All patients with unilateral adenomas (11) achieved remission, whereas outcomes in bilateral disease were heterogeneous (50% no remission, 25% temporary [21-276 months], 25% permanent). 9 patients were included in relacorilant trial (6 bilateral adenomas, 3 post-unilateral relapse). Conclusions MACS patients have significant prevalence of cardiometabolic, thromboembolic, skeletal, hepatic and psychological complications. These findings challenge the perception of MACS as a benign condition and underscore the need for refined risk stratification and prospective studies to better define morbidity and guide treatment strategies.